Abstract | OBJECTIVE: METHODS: The concentrations of UHRF1 DNA in serum were compared between 187 GC patients and 56 healthy controls using real-time PCR. Immunohistochemical analysis using tissue microarrays was performed. RESULTS: UHRF1 DNA levels were significantly higher in GC patients compared to healthy controls (p < 0.001) and have associations with age and lymph node metastasis (LNM). The UHRF1 expression was significantly higher in tumor tissue than matched normal tissues (p < 0.001). CONCLUSIONS: The UHRF1 expression in serum and tissue may represent a novel biomarker for GC diagnosis and prognosis.
|
Authors | Mengyuan Ge, Zhen Gui, Xiaoming Wang, Feng Yan |
Journal | Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
(Biomarkers)
Vol. 20
Issue 3
Pg. 183-8
( 2015)
ISSN: 1366-5804 [Electronic] England |
PMID | 26161699
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers, Tumor
- CCAAT-Enhancer-Binding Proteins
- DNA, Neoplasm
- UHRF1 protein, human
- Ubiquitin-Protein Ligases
|
Topics |
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Base Sequence
- Biomarkers, Tumor
(blood, genetics)
- CCAAT-Enhancer-Binding Proteins
(blood, genetics)
- Case-Control Studies
- DNA, Neoplasm
(blood, genetics)
- Female
- Gene Expression
- Humans
- Lymphatic Metastasis
- Male
- Middle Aged
- Molecular Sequence Data
- Neoplasm Staging
- Prognosis
- Stomach Neoplasms
(blood, diagnosis, genetics)
- Tissue Array Analysis
- Ubiquitin-Protein Ligases
|